Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
Filing tables
Filing exhibits
- 20-F Annual report (foreign)
- 2.1 Description of Securities
- 8.1 List of Principal Subsidiaries
- 12.1 Certification
- 12.2 Certification
- 13.1 Certification
- 13.2 Certification
- 15.1 Consent of Wei, Wei & Co., LLP., an Independent Registered Public Accounting Firm for Ys Biopharma
- Download Excel data file
- View Excel data file
LSB similar filings
Filing view
External links
Exhibit 15.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM | |
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (File No. 333-273165) of our report dated July 26, 2023, relating to the consolidated financial statements of YS Biopharma Co., Ltd. and subsidiaries as of March 31, 2023 and 2022, and for each of the years in the three-year period ended March 31, 2023, which appears in this Annual Report on Form 20-F. | |
/s/ Wei, Wei & Co., LLP | |
Flushing, New York | |
July 26, 2023 |